Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Psychiatric Services

A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSamuel R. BuntingADAparna DasLILuca Iacobelli

Discussion

Loading...

Member takes

Overview

Analysis describes clozapine availability in U.S. mental health facilities, indicating underutilization issues.

Key Points

  • Clozapine availability varies across mental health facilities in the U.S., impacting treatment access.
  • The study highlights systemic barriers affecting clozapine use in mental health services.
  • Findings suggest addressing prescriber and patient factors could improve clozapine accessibility.
  • Understanding facility-level availability is crucial for enhancing mental health treatment options.

Cite This Study

Bunting et al. (2025) studied this question.

synapsesocial.com/papers/68dd89defe798ba2fc497bdahttps://doi.org/10.1176/appi.ps.20250098
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Declines and pronounced state-level variation in clozapine use among Medicare patients2025
  2. 2Clozapine: prescribing practices in French psychiatric hospitals, multicenter survey on a given day2025
  3. 3THE USE OF CLOZAPINE IN PAKISTAN: A STUDY BASED ON CLOZARIL PATIENTS MONITORING SYSTEM (CPMS)2025
  4. 4Clozapine: prevalence and modalities of associations with antipsychotics and mood stabilizer in French psychiatric hospitals. Multicenter survey on a given day2025
  5. 5496. THE BENEFITS OF CLOZAPINE BEYOND ITS ANTIPSYCHOTIC PROPERTIES IN TREATMENT-RESISTANT SCHIZOPHRENIA2025